Video from AACC: PerkinElmer on diagnostics, acquisitions

By Leo O'Connor, Editor in Chief
August 2, 2022

Greg Stock, general manager of PerkinElmer’s Euroimmun business, discussed products and technologies on display at AACC 2022, as well as the integration of acquired companies such as Oxford Immunotec.

Click on the video below for the interview.

PerkinElmer interview at AACC
Greg Stock, general manager of PerkinElmer's Euroimmun business.

PerkinElmer, Novartis expand newborn screening for SCD
PerkinElmer on Thursday announced that it is collaborating with Novartis to expand newborn screening for sickle cell disease (SCD) in sub-Saharan Africa.
PerkinElmer highlights cell and gene therapy at SLAS 2022
PerkinElmer is highlighting its portfolio of cell and gene therapy products, as well as automatic genomic workflows, at the Society for Laboratory Automation...
PerkinElmer launches kit to detect SARS-CoV-2 variants
PerkinElmer has launched a research-use-only SARS-CoV-2 test kit to accelerate the detection of variants, including omicron.
PerkinElmer receives EUA for respiratory SARS-CoV-2 panel
PerkinElmer has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its PKamp Respiratory SARS-CoV-2 reverse...

Copyright © 2022

Last Updated 8/2/2022 7:09:01 AM